Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease

Persistent gestational trophoblastic disease is potentially fatal, but the majority of patients are cured with chemotherapy. Any developments in treatment are therefore being directed towards maintaining efficacy and reducing toxicity. We evaluated efficacy and toxicity of methotrexate, etoposide an...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Dobson, L S, Lorigan, P C, Coleman, R E, Hancock, B W
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2000
Sujets:
Regular Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363400/
https://ncbi.nlm.nih.gov/pubmed/10789722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1176
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires